Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.2.1.84 - glucan 1,3-alpha-glucosidase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Carcinogenesis
Glucosidase II beta subunit (GluII?) plays a role in autophagy and apoptosis regulation in lung carcinoma cells in a p53-dependent manner.
Carcinoma
Glucosidase II beta subunit (GluII?) plays a role in autophagy and apoptosis regulation in lung carcinoma cells in a p53-dependent manner.
Carcinoma, Hepatocellular
Endoplasmic reticulum stress underlying the pro-apoptotic effect of epigallocatechin gallate in mouse hepatoma cells.
Glucosidase II, a protein of the endoplasmic reticulum with high mannose oligosaccharide chains and a rapid turnover.
[Effect of green tea flavanols on the functions of the endoplasmic reticulum.]
Dental Plaque
Purification and properties of an ?-(1 ? 3)-glucanase (EC 3.2.1.84) from Trichoderma harzianum and its use for reduction of artificial dental plaque accumulation.
Diabetes Mellitus, Type 2
Metabolic syndrome perturbs deglucosylation and reglucosylation in the glycoprotein folding cycle.
Infections
Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors.
Proteomics analysis reveals novel host molecular mechanisms associated with thermotherapy of 'Ca. Liberibacter asiaticus'-infected citrus plants.
Liver Diseases
Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease.
Mutations in SEC63 cause autosomal dominant polycystic liver disease.
N-glycosylation determines the abundance of the transient receptor potential channel TRPP2.
Polycystic liver disease is a disorder of cotranslational protein processing.
Lung Neoplasms
Knockout of glucosidase II beta subunit inhibits growth and metastatic potential of lung cancer cells by inhibiting receptor tyrosine kinase activities.
Lymphoma
A lectin-resistant mouse lymphoma cell line is deficient in glucosidase II, a glycoprotein-processing enzyme.
Expression of a cDNA encoding the glucose trimming enzyme glucosidase II in CHO cells and molecular characterization of the enzyme deficiency in a mutant mouse lymphoma cell line.
Identification of a novel mechanism for the removal of glucose residues from high mannose-type oligosaccharides.
Identity of neutral alpha-glucosidase AB and the glycoprotein processing enzyme glucosidase II. Biochemical and genetic studies.
N-linked oligosaccharide processing enzyme glucosidase II produces 1,5-anhydrofructose as a side product.
The effect of castanospermine on the oligosaccharide structures of glycoproteins from lymphoma cell lines.
Metabolic Syndrome
Metabolic syndrome perturbs deglucosylation and reglucosylation in the glycoprotein folding cycle.
Neoplasms
Glucosidase II exhibits similarity to the p53 tumor suppressor in regards to structure and behavior in response to stress signals: A potential novel cancer biomarker.
Knockout of glucosidase II beta subunit inhibits growth and metastatic potential of lung cancer cells by inhibiting receptor tyrosine kinase activities.
Proteomic and functional genomic landscape of receptor tyrosine kinase and ras to extracellular signal-regulated kinase signaling.
Obesity
Metabolic syndrome perturbs deglucosylation and reglucosylation in the glycoprotein folding cycle.
Polycystic Kidney Diseases
GANAB and PKD1 Variations in a 12 Years Old Female Patient With Early Onset of Autosomal Dominant Polycystic Kidney Disease.
Polycystic Kidney, Autosomal Dominant
GANAB and PKD1 Variations in a 12 Years Old Female Patient With Early Onset of Autosomal Dominant Polycystic Kidney Disease.
Vesicular Stomatitis
Identification of a novel mechanism for the removal of glucose residues from high mannose-type oligosaccharides.